BMC Ophthalmology is calling for submissions to our Collection on uveitis. Uveitis is a complex group of disorders characterized by inflammation of the uvea, which includes the iris, ciliary body, and choroid. This sight-threatening condition can lead to visual impairment and even blindness if not promptly diagnosed and effectively managed.
Diagnosing and treating uveitis pose substantial challenges due to the intricate interplay of genetic, environmental, and immunological factors. Early diagnosis is crucial for initiating appropriate treatment strategies. Current treatment options often rely on corticosteroids and immunosuppressive agents. There is an urgent need for innovative and personalized treatment approaches to achieve better disease control and minimize ocular morbidity.
Potential topics can include, but are not limited to, the following:
• Novel diagnostic approaches, including imaging and biomarkers.
• Advancements in the understanding of uveitis pathogenesis and its genetic basis.
• Therapeutic innovations, such as targeted immunotherapies or gene therapies.
• The role of the immune system in the onset and development of uveitis.
• Impact of uveitis in vision and ocular complications.
• Surgical management of uveitis.
Image credit: Ester Carreño
